It is a major immunodominant antigen that is considered to have potential as a vaccine against tuberculosis, and can elicit proliferation of both CD4+ and CD8+ T cells and IFN-γ secretion in healthy people with LTBI44. This evidence concerns the gene CD8A and tuberculosis.